Eledon Pharmaceuticals, Inc. — All Filings
594 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
424B2
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
EFFECT
FWP
IRANNOTICE
NT 10-Q
PRE 14A
PREM14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001125 | Mar 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-116164 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-116154 | Mar 19, 2026 | — |
| SCHEDULE 13G/A | — | 0001346824-26-000041 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015219 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0002012383-26-000664 | Jan 21, 2026 | — |
| 4 | 4 | 0001193125-26-015489 | Jan 16, 2026 | Jan 10, 2026 |
| 4 | 4 | 0001193125-26-015488 | Jan 16, 2026 | Jan 10, 2026 |
| 4 | 4 | 0001193125-26-015487 | Jan 16, 2026 | Jan 10, 2026 |
| 4 | 4 | 0001193125-26-015486 | Jan 16, 2026 | Jan 10, 2026 |
| 4 | 4 | 0001193125-26-015485 | Jan 16, 2026 | Jan 10, 2026 |
| 4 | 4 | 0001193125-26-015484 | Jan 16, 2026 | Jan 10, 2026 |
| 8-K | 8-K | 0001193125-26-000968 | Jan 2, 2026 | Dec 30, 2025 |
| SCHEDULE 13G | — | 0001104659-25-115374 | Nov 24, 2025 | — |
| 8-K | 8-K | 0001193125-25-283294 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-283275 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-278392 | Nov 13, 2025 | Nov 12, 2025 |
| 424B5 | 424B5 | 0001193125-25-278390 | Nov 13, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-275606 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-270286 | Nov 7, 2025 | Nov 6, 2025 |
| 10-Q | 10-Q | 0001193125-25-180906 | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q/A | 10-Q/A | 0001193125-25-180904 | Aug 14, 2025 | Mar 31, 2025 |
| 10-K/A | 10-K/A | 0001193125-25-180865 | Aug 14, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-180820 | Aug 14, 2025 | Aug 11, 2025 |
| 8-K | 8-K | 0000950170-25-103975 | Aug 6, 2025 | — |
| SCHEDULE 13G | — | 0000932471-25-000874 | Jul 29, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-003025 | Jul 17, 2025 | — |
| 8-K | 8-K | 0000950170-25-085588 | Jun 12, 2025 | Jun 10, 2025 |
| 10-Q | 10-Q | 0000950170-25-071582 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-071370 | May 14, 2025 | — |
| ARS | ARS | 0000950170-25-060324 | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-060316 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-060299 | Apr 29, 2025 | Jun 10, 2025 |
| PRE 14A | PRE 14A | 0000950170-25-053771 | Apr 14, 2025 | Jun 10, 2025 |
| 8-K/A | 8-K/A | 0000950170-25-053765 | Apr 14, 2025 | Apr 1, 2025 |
| 8-K | 8-K | 0000950170-25-051663 | Apr 7, 2025 | Apr 1, 2025 |
| 10-K | 10-K | 0000950170-25-042754 | Mar 20, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-042644 | Mar 20, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001292 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-003986 | Feb 14, 2025 | — |
| 4 | 4 | 0000950170-25-004925 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004924 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004923 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004918 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004922 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004921 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004916 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004915 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004920 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | 4 | 0000950170-25-004914 | Jan 13, 2025 | Jan 10, 2025 |